Prevalence of human T-cell lymphotropic virus type 1 or 2 among blood donors screened at the New Zealand Blood Service: An observational study, 2001–2024
Prevalence of HTLV-1/2 infection among blood donors in New Zealand was very low, with no evidence of infection among Māori and Pacific donors, suggesting that a wider HTLV-1/2 seroprevalence study was unlikely to be necessary.
Authors
- Wendy L. Bennett (ORCID: https://orcid.org/0000-0001-9828-0706)
- Michelle Balm (ORCID: https://orcid.org/0000-0002-2969-1277)
- Phyu Sin Aye (ORCID: https://orcid.org/0000-0001-9356-9965)
- Karen Bartholomew (ORCID: https://orcid.org/0000-0002-1517-2134)
- Collette Bromhead (ORCID: https://orcid.org/0000-0002-2890-2191)
- Sue Crengle (ORCID: https://orcid.org/0000-0001-9367-1492)
- Lucy Gray
- Richard Charlewood (ORCID: https://orcid.org/0000-0002-1798-1189)
Institutions
- University of Auckland (NZ)
- Health Outcomes Solutions (United States) (US)
- Health Promotion Agency (NZ)
- Capital and Coast District Health Board (NZ)
- Massey University (NZ)
- University of Otago (NZ)
Publication Details
- Journal
- Preventive Medicine Reports
- Published
- 2025-08-22
- DOI
- https://doi.org/10.1016/j.pmedr.2025.103223
- Primary Topic
- T-cell and Retrovirus Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00